Biomarkers Enabling Precision Medicine Decisions Across Drug Discovery and Clinical Development
Evotec delivers integrated biomarker solutions that enable confident, data-driven decisions from early discovery through clinical development. By combining biomarker strategy design, advanced assay platforms, multi-omics technologies, and access to clinically relevant human samples, Evotec supports precision medicine across key therapeutic areas, including oncology, immuno-oncology, neuroscience, autoimmune diseases, and others. Biomarker activities are embedded across the drug discovery and development continuum to ensure alignment with therapeutic objectives and regulatory intent.
>20
Years experience in biomarker strategy design
>1,000
Assays developed annually
>60
Clients on an annual basis
>20
Years experience in biomarker strategy design
>1,000
Assays developed annually
>60
Clients on an annual basis
The applications below highlight how Evotec’s biomarker expertise is applied in practice, from early discovery to clinical development and trial support, ensuring biomarker data is translated into actionable insight across programs and platforms.
Precision Medicine
Precision medicine is a tailored approach to treatment and prevention that accounts for individual differences in genes, environment, and lifestyle. By aligning therapies with each patient’s biological profile, it enables accurate diagnoses, greater efficacy, and fewer side effects.
By integrating biomarker science, multi-omics tools, and patient-relevant models, precision medicine supports the creation of therapies matched to molecular disease features. This approach improves outcomes and reduces trial failures, expediting drug development and regulatory approval.
Figure 1. Role of precision medicine.
Driving Clinical Success Through Translational Biomarkers
Translational biomarkers play a central role in improving the efficiency and success of clinical development. By linking molecular insights to patient outcomes, biomarkers inform critical decisions across trial design, execution, and regulatory interaction. From identifying the right patients to optimizing development strategies and supporting regulatory confidence, biomarker-driven approaches enable more targeted, efficient, and predictable clinical programs.
Diverse Biomarkers Across Discovery & Clinical Development
Biomarkers are central to modern drug development, guiding decisions from disease detection to treatment response and enabling more targeted, efficient, and predictive development strategies across the clinical continuum.
